You are here: Industry Insights > Market News > Jenburkt Pharma to consider share buyback

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Jenburkt Pharma to consider share buyback

expressbpdSeptember 08, 2017

Tag: Jenburkt Pharma , share , buyback

Favorites

The board of directors to meet later this week

Jenburkt Pharmaceuticals’ board will meet later this week to consider buy back of equity shares, sending its stock up by 8 per cent.

"A meeting of the Board of Directors of the company is scheduled to be held on September 9, 2017, inter alia, to consider matters related to buyback of the fully paid-up equity shares of the company," Jenburkt Pharmaceuticals said in a regulatory filing.

The company, however, did not elaborate on the size of the buyback.

Previous:GIBS 2017 held in Mumbai

Next:Deals this week: Mundipharma Medical Company, Cooper Pharmal Sarl, Merck

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Jenburkt Pharma to consider share buyback | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

View larger image Share to: Add to My Favorites Strong aroma Clarifying natural Citronella es

Share to: Add to My Favorites Oreganum Vulgare Oil 90% Carvacrol

View larger image Share to: Add to My Favorites EXTRA VIRGIN OLIVE OIL

Share to: Add to My Favorites Cold Pressed Castor Oil

all natural Ginger oilShare to: Add to My Favorites pure ginger essential oil in stock

PHENOXYMETHYL PENICILLIN POTASSIUM

LINCOMYCIN HCL

GENTAMYCIN SULPHATE macrolides

CEFALEXINE cephalosporins

CEFRADINE cephalosporins

Jenburkt Pharma to consider share buyback

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>